Evidence map›Paper›PMID 36636232›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2022

Yongkang Qiu, Hao Jiao, Wenpeng Huang, Zhao Chen, Qi Yang, Sitong Wu, Xinyao Sun, Lei Kang

Open access · greenAbstract readCase Reports
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yongkang QiuDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Hao JiaoDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Qi YangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Sitong WuDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Xinyao SunDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital Beijing 100034, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma (MM) is an aggressive malignant tumor, which mostly occurs on the skin, uvea, etc. The mucosal MM accounts for a small proportion of all MM and can occur in the digestive tract. Primary MM of the digestive tract is rare and can be found in the middle and lower third of the esophagus and the rectum containing melanocytes. Primary rectal MM often occurs in middle-aged and elderly women, with rapid progress and strong invasion. We report a case of a 61-year-old man diagnosed with primary malignant melanoma of the rectum with liver metastases mimicking rectum cancer.

Indexed as

18F-FDGMalignant melanomaPET/CTprimaryrectum

Identifiers

PMID36636232
PMCPMC9831859
OpenAlexW4315927695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.